Follow Us
https://www.thebody.com/category/truvada
HIV Treatment and Medical Care

Truvada (Tenofovir/FTC)

The Latest

selective focus image of Gilead Truvada for PrEP
News Analysis

The Government's Free PrEP Isn't (Necessarily) Free

Ready, Set, PrEP expands access to pre-exposure prophylaxis meds, but it doesn't cover other costs.

Transgender Day of Remembrance
News

Many Brave the Cold Winds for New York City's 20th Annual Transgender Day of Remembrance

"Let these names burn in your heart to fuel your desire to live."

Truvada HIV PrEP Drug - Blue Gilead Sciences Pills
News Analysis

Descovy and Truvada Are Both Available for PrEP. But What's the Difference?

As Gilead pressures health care providers to switch to the newer drug, here's some information to make sure you can make the best decision for your health.

Gilead Sciences headquarters in the Silicon Valley, Foster City, California
News Analysis

Much Ado About Descovy

While many celebrated the FDA approval of Descovy for PrEP earlier this month, advocates wonder whether it will make biomedical HIV prevention more or less accessible to those most in need.

Targeted Truvada ads
News Analysis

Those Truvada Lawsuit Ads You See Everywhere May Hinder Public Health Efforts

Personal injury lawsuit ads targeting social media have become daily sightings. But are they doing more harm than good?

 U.S. Sen. Kamala Harris (D-CA) speaks at the National Action Network's annual convention, April 5, 2019 in New York City.
News

Kamala Harris Announces New Bill to Expand PrEP Access

The PrEP Access and Coverage Act would guarantee insurance coverage for PrEP and fund PrEP for the uninsured.

PrEP still life, selective focus
News Analysis

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

illustration of person on cliff with arms raised as sun rises/sets
News

This Week in HIV Research: From PrEP to Treatment, There's Always More to Learn

April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.

Doctors Aren't Offering Young People PrEP. That Has to Change. Img
News

Doctors Aren't Offering Young People PrEP. That Has to Change.

For LGBT Health Awareness Week, educator Tyunique Nelson argues that PrEP education and access for youth have to be a top priority.

Promo Image
News

This Week in HIV Research: Renal Upsides for Tenofovir Alafenamide

E/C/F/TAF viability for dialysis patients; TAF safety following renal damage; mental health needs for American Indians; parenting desires of people with HIV.